Earlier this year, Neurovalens announced the 2022 Rosenman Innovator has received medical device clearance from the FDA to treat anxiety […]
Neurovalens Receives FDA Clearance for Anxiety Treatment Device
![](https://rosenmaninstitute.org/wp-content/uploads/2024/07/Neurovalens-1024x684.png)
Earlier this year, Neurovalens announced the 2022 Rosenman Innovator has received medical device clearance from the FDA to treat anxiety […]
The 2023 ADAPT Finalist has raised a $14 million Series A funding round to enhance Backpack Healthcare’s technology platform, expand […]
ConKay Medical Systems is a 2023 Rosenman Innovator and medtech start-up company. Conkay’s innovative technology helps treat patients suffering from […]
The FDA has granted 510(k) clearance to the ZETO ONE, an innovative next-generation EEG Brain Monitoring product. Zeto’s Founder, Aswin […]
2023 Rosenman Innovator, Averto Medical, has raised an oversubscribed $30.5 million Series A financing. This financing will support advancing Averto […]
The 2023 Rosenman Innovator raised $6M in funding to expand its virtual dermatology clinic services The 2023 Rosenman Innovator raised […]
2022 ADAPT Finalist, Midi Health, closed a $60M Series B funding round San Francisco – 2022 ADAPT Finalist, Midi Health, […]
Efemoral Medical is a 2022 Rosenman Innovator and developer of the Efemoral Vascular Scaffold System (EVSS) for the treatment of peripheral […]
Bloomlife, a 2019 Rosenman Innovator and award winning maternal health company, has gained FDA clearance for their first maternal and […]
2023 ADAPT Finalist, Isaac Health, successfully completed an oversubscribed $5.7 million Seed round to redefine the future of brain healthcare […]